Substituted aminothiazoles for the treatment of tuberculosis

US10221169B2 · kind B2 · utility

Assignees

• The Broad Institute, Inc. · US
• The General Hospital Corporation · US
• The Brigham and Women's Hospital, Inc. · US

Inventors

• Deborah Hung · Cambridge, US
• Michael H. Serrano-Wu · Cambridge, US
• Sarah Grant · Boston, US
• Tomohiko Kawate · Cambridge, US

Key dates

• Filing date: Mar 23, 2017
• Grant date: Mar 5, 2019
• Expiry date: Mar 23, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Disclosed ore substituted aminothiazoles, which can be used for, among other things, the treatment of tuberculosis, pharmaceutical compositions containing the same, and methods of using the same.